ПЭТ/КТ с 18F-фторэтилтирозином в диагностике лучевого некроза в височной доле головного мозга после лучевого лечения рака носоглотки (клиническое наблюдение)

Представлено клиническое наблюдение больного раком носоглотки после  стереотаксического радиохирургического лечения по поводу продолженного роста рака  носоглотки после химиолучевой терапии. В анализ были включены диагностические  данные, полученные после проведенных ПЭТ/КТ с 18F-фторэтилтирозином (18F-ФЭТ) и МРТ  с внутривенным контрастированием головы и шеи. Проанализирован случай дифференциальной диагностики  изменений в височной доле головного мозга после стереотаксической лучевой терапии рака  носоглотки при помощи ПЭТ/КТ с 18F-ФЭТ. Определена высокая диагностическая точность  метода в дифференциальной диагностике отсроченных изменений в головном мозге  (опухолевые или лучевой некроз) после проведенной повторной лучевой терапии рака носоглотки.

1. Chen J., Dassarath M., Yin Z., Liu H., Yang K., Wu G. Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management. Radiation Oncology. 2011; 6: 128. DOI: 10.1186/1748-717X-6-128.

2. De Salvo M.N. Radiation necrosis of the pons after radiotherapy for nasopharyngeal carcinoma: diagnosis and treatment. J. Radiol. Case Rep. 2012; 6 (7): 9–16. DOI: 10.3941/jrcr.v6i7.1108.

3. Hsu Y.-C., Wang L.-F., Lee K.-W., Ho K.-Y., Huang C.-J., Kuo W.-R. Сerebral radionecrosis in patients with nasopharyngeal carcinoma. Kaohsiung J. Med. Sci. 2005; 21 (10): 452–459. DOI: 10.1016/S1607-551X(09)70150-0.

4. Sheline G.E., Wara W.M., Smith V. Therapeutic irradiation and brain injury. Int. J. Radiat. Oncol. Biol. Phys. 1980; 6: 1215–1228.

5. Qin D.X., Hu Y.H., Yan J.H., Xu G.Z., Cai W.M., Wu X.L., Cao D.X., Gu X.Z. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer. 1988; 61: 1117–1124.

6. Lee A.W., Ng S.H., Ho J.H., Tse V.K., Poon Y.F., Tse C.C., Au G.K., O S.K., Lau W.H., Foo W.W. Clinical diagnosis of late temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma. Cancer. 1988; 61: 1535–1542.

7. Fischer A.W., Holfelder H. Lokales Amyloid in Gehirn. Einespatfolge von rontgenbestrahlungen. Dtsch. Z. Chir. 1930; 227: 475–483.

8. Glass J.P.,Hwang T.L., Leavens M.E., Libshitz H.I. Cerebral radiation necrosis following treatment of extracranial malignancies. Cancer. 1984; 54: 1966–1972.

9. MarksJ. E., Wong J. The risk of cerebral radionecrosis in relation to dose, time and fractionation: a follow-up study. Prog. Exp. Tumor Res. 1985; 29: 210–218.

10. Ruben J.D., Dally М., Bailey М., Smith R., McLean C.A., Fedele P. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2006; 65: 499–508. DOI: 10.1016/j.ijrobp.2005.12.002.

11. Савинцева Ж.И., Скворцова Т.Ю., Бродская З.Л. Современные методы нейровизуализации в дифференциальной диагностике лучевых поражений головного мозга у больных с церебральными опухолями. Лучевая диагностика и терапия. 2012; 1 (3): 15–23.

12. Крячок И.А. Новый подход к лечению пациентов с пострадиационным некрозом головного мозга. Онкология. 2010; 12 (3): 261–262.

13. Burger Р.С., Boyko O.B. The pathology of central nervous system radiation injury. Radiation injury to the nervous system. Eds Gutin P.H., Leibel S.A., Sheline G.E. New York: Raven, 1991: 191–208.

14. Castel J.C., Caille J.M. Imaging of irradiated brain tumors: value of magnetic resonance imaging. J. Neuradiol. 1989; 16: 81–132.

15. Sawaya R. The fibrinolytic enzymes in the biology of brain tumors. Sawaya M. D. (ed). Fibrilysis and the central nerv system. Philadelphia, Pa: Harnley and Belfus, 1990: 106–126.

16. Li Y.Q., Chen P., Haimovitz-Friedman A., Reilly R.M., Wong C.S. Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. Cancer Res. 2003; 63 (18): 5950–5956.

17. Шишкина Л.В. Патологическая анатомия осложнений у нейроонкологических больных после лучевой терапии: Автореф. дисс. … канд. мед. наук. М., 1988. 18 с.

18. Никитин К.В., Шишкина Л.В., Пронин И.Н., Ильялов С.Р., Костюченко В.В., Голанов А.В. Лучевой некроз после стереотаксической радиохирургии доброкачественной глиомы: описание случая. Вопросы нейро хирургии им. Н.Н. Бурденко. 2009; 3: 37–42.

19. Monje M.L., Toda H., Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science. 2003; 302 (5651): 1760–1765. DOI: 10.1126/science.1088417.

20. Wilson C.M., Gaber M.W., Sabek O.M., Zawaski J.A., Merchant T.E. Radiation-induced astrogliosis and bloodbrain barrier damage can be abrogated using anti-TNF treatment. Int. J. Radiat. Oncol. Biol. Phys. 2009; 74 (3): 934–941. DOI: 10.1016/j.ijrobp.2009.02.035.

21. Zhou H., Liu Z., Liu J., Zhou D., Zhao Z., Xiao S., Tao E., Suo W.Z. Fractionated radiation- induced acute encephalopathy in a young rat model: cognitive dysfunction and histologic findings. Am. J .Neuroradiol. 2011; 32 (10): 1795–1800. DOI: 10.3174/ajnr.A2643.

22. Safdari Н., Fuentes J.M. Dubois J.B., Alirezai M., Castan P., Vlahovitch B. Radiation necrosis of the brain: Time of onset and incidence related to total dose and fractionation of radiation. Neuroradiology. 1985; 27: 44–47.

23. Lee A.W.M., Law S.C.K., Ng S.H., Chan D.K., Poon Y.F., Foo W., Tung S.Y., Cheung F.K., Ho J.H. Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985: late complications following megavoltage irradiation. Br. J. Radiol. 1992; 65: 918–928. DOI: 10.1259/0007-1285-65-778-918.

24. Chong V.F., Fan Y.F., Mukherji K.S. Radiation-Induced Temporal Lobe Changes: CT and MR Imaging Characteristics. Am. J. Roentgenol. 2000; 175: 431–436. DOI: 10.2214/ajr.175.2.1750431.

25. Lee A.W., Foo W., Chappell R., Fowler J.F., Sze W.M., Poon Y.F., Law S.C., Ng S.H., O S.K., Tung S.Y., Lau W.H., Ho J.H. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1998; 40: 35–42.

26. Tandon N., Vollmer D., New P., Hevezi J.M., Herman T., Kagan-Hallet K., West G.A. Fulminant radiation-induced necrosis after stereotactic radiation therapy to the posterior fossa. Case report and review of the literature. J. Neurosurg. 2001; 95: 507–512. DOI: 10.3171/jns.2001.95.3.0507.

27. Chin L.S., Ma L., DiBiase S. Radiation necrosis following gamma knife surgery: a case- controlled comparison of treatment parameters and long-term clinical follow up. J. Neurosurg. 2001; 94: 899–904. DOI: 10.3171/jns.2001.94.6.0899.

28. Chen H., Burnett M., Huse J., Lustig R.A., Bagley L.J., Zager E.L. Recurrent late cerebral necrosis with aggressive characteristics after radiosurgical treatment of an arteriovenous malformation. Casereport J. Neurosurg. 2006; 105: 455–460. DOI: 10.3171/jns.2006.105.3.455.

29. Cheng K.M., Chan C.M., Fu Y.T., Ho L.C., Tsang Y.W., Lee M.K., Cheung Y.L., Law C.K. Brain abscess formation in radiation necrosis of the temporal lobe following radiation therapy for nasopharyngeal carcinoma. Acta Neurochir. (Wien). 2000; 142: 435–440.

30. Cheng K.M., Chan C.M., Fu Y.T., Ho L.C., Cheung F.C., Law C.K. Acute hemorrhage in late radiation necrosis of the temporal lobe: report of five cases and review of the literature. J. Neurooncol. 2001; 51: 143–150.

31. Giglio P., Gilbert M. Cerebral Radiation Necrosis. The Neurologist. 2003; 9: 180–188. DOI: 10.1097/01.nrl.0000080951.78533.c4.

32. Dooms G.C., Hecht S., Brant-Zawadzki M., Berthiaume Y., Norman D., Newton T.H. Brain radiation lesions: MR imaging. Radiology. 1986; 158: 149–155. DOI: 10.1148/radiology.158.1.3940373.

33. Galldiks N., Stoffels G., Filss C., Piroth M.D., Sabel M., Ruge M.I., Herzog H., Shah N.J., Fink G.R., Coenen H.H., Langen K.J. Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis. J. Nuclear Med. 2012; 53 (9): 1367–1374. DOI: 10.2967/jnumed.112.103325.

34. Скворцова Т.Ю., Бродская З.Л., Савинцева Ж.И., Гурчин А.Ф. Современные проблемы мониторинга лече ния церебральных глиом и возможности повышения точности диагностики при помощи ПЭТ с [11С]метионином. Лучевая диагностика и терапия. 2014; 2 (5): 5–16. http://dx.doi.org/10.22328/2079-5343-2014-2-5-16.

35. Kreth F.W., Muacevic A., Medele R., Bise K., Meyer T., Reulen H.J. The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours- a pro spective study. Acta Neurochirurgica. 2001; 143 (6): 539–546.

36. Heper A.O., Erden E., Savas A., Ceyhan K., Erden I., Akyar S., Kanpolat Y. An analysis of stereotactic biopsy of brain tumors and nonneoplastic lesions: a prospective clinicopathologic study. Surg. Neurol. 2005; 30; 64: 82–88. DOI: 10.1016/j.surneu.2005.07.055.

37. Grosu A.L., Astner S.T., Riedel E., Nieder C., Wiedenmann N., Heinemann F., Schwaiger M., Molls M., Wester H.J., Weber W.A. An Interindividual Comparison of O-(2- [18F] Fluoroethyl)- L-Tyrosine (FET)-and L-[Methyl-11C] Methionine (MET)-PET in Patients With Brain Gliomas and Metastases. Int. J. Radiat. Oncol. Biol. Phys. 2011; 81 (4): 1049–1058. DOI: 10.1016/j.ijrobp.2010.07.002.

38. Palumbo B., Buresta T., Nuvoli S., Spanu A., Schillaci O., Fravolini M.L., Palumbo I. SPECT and PET serve as molecular imaging techniques and in Vivo biomarkers for brain metastases. Int. J. Molec. Sci. 2014; 15 (6): 9878–9893. DOI: 10.3390/ijms15069878.

39. Stöber B., Tanase U., Herz M., Seidl C., Schwaiger M., Senekowitsch-Schmidtke R. Differentiation of tumour and inflammation: characterisation of [methyl-3H] methionine (MET) and O-(2-[18F] fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells. Eur. J Nucl. Med. Molec. Imaging. 2006; 33 (8): 932–939. DOI: 10.1007/s00259-005-0047-5.

40. Hanakawa K., Ikeda H., Ishii K., Asamoto S., Iwata T., Matsumoto K. High uptake on 11C methionine PET scan in the pituitary gland of a patient with cerebral glioma after surgical abortion. No To Shinkei. 1998; 50 (6): 573–577.

41. Позитронная эмиссионная томография: Руководство для врачей; Под ред. А.М. Гранова и Л.А. Тютина. М.: Фолиант, 2008. 610 c.

42. Карташев А.В., Виноградов В.М., Киселева Л.Н.. Злокачественные глиомы головного мозга. Lambert Academic Publishing. 2011; 166–168.

43. Pöpperl G., Götz C., Rachinger W., Gildehaus F.J., Tonn J.C., Tatsch K.Value of O-(2-[18F] fluoroethyl)-Ltyrosine PET for the diagnosis of recurrent glioma. Eur. J. Nucl. Med. Molec. Imaging. 2004; 31 (11): 1464–1470. DOI: 10.1007/s00259-004-1590-1.

44. Langen K.J., Hamacher K., Weckesser M., Floeth F., Stoffels G., Bauer D., Coenen H.H., Pauleit D. O-(2-[18F] fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl. Med. Biol. 2006; 33 (3): 287–294. DOI: 10.1016/j.nucmedbio.2006.01.002.

45. Jensen M.L. Image Analysis of FET PET scans performed during Chemo-Radiotherapy of Glioblastoma Multiforme. DTU Informatics. 2012: 8–14.

46. Juhász C., Dwivedi S., Kamson D.O., Michelhaugh S.K., Mittal S. Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors. Molec. Imaging. 2014; 13 (6): 7290–2014.

47. Pöpperl G., Kreth F.W., Herms J., Koch W., Mehrkens J.H., Gildehaus F.J., Kretzschmar H.A., Tonn J.C., Tatsch K. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J. Nucl. Med. 2006; 47 (3): 393–403.

48. Piroth M.D., Liebenstund S., Galldiks N., Stoffels G., ShahN. J., EbleM. J., Coenen H.H., Langen K.J. Monitoring of Radiochemotherapy in Patients with Glioblastoma Using O-(2- [18F] Fluoroethyl)-L-Tyrosine Positron Emission Tomography: Is Dynamic Imaging Helpful? Molec. Imaging. 2013; 12 (6): 7290–2013.

49. Di Chiro G., De LaPaz R.L., Brooks R.A., Sokoloff L., Kornblith P.L., Smith B.H., Patronas N.J., Kufta C.V., Kessler R.M., Johnston G.S., Manning R.G., Wolf A.P. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. eurology. 1982; 32 (12): 1323.

50. Bělohlávek O., Šimonová G., Kantorová I., Novotný J. Jr., Liscák R. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression? Eur. J. Nucl. Med. Molec. Imaging. 2003; 30 (1): 96– 100. DOI: 10.1007/s00259-002-1011-2.

51. Lee H.Y., Chung J.K., Jeong J.M., Lee D.S., Kim D.G., Jung H.W., Lee M.C. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer. Ann. Nucl. Med. 2008 ; 22 (4): 281–286. DOI: 10.1007/s12149-007-0104-1.

52. Трофимова Т.Н., Трофимов Е.А. Современные стратегии лучевой диагностики при первичных опухолях головного мозга. Практическая онкология. 2013; 14 (3): 141–147.

53. Molecular anatomic imaging: PET-CT and SPECT-CT integrated modality imaging. Ed. Von Schulthess G.K. Lippincott Williams & Wilkins, 2007: 150–152.

54. Hutterer M., Nowosielski M., Putzer D., Jansen N.L., Seiz M., Schocke M., McCoy M., Göbel G., laFougère C., Virgolini I.J., Trinka E., Jacobs A.H., Stockham mer G. [18F]-fluoro- ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma. Neurooncology. 2013; 341–351. DOI: 10.1093/neuonc/nos300.

55. Unterrainer M., Schweisthal F., Suchorska B., Wenter V., Schmid-Tannwald C., Fendler W.P., Schüller U., Bartenstein P., Tonn J.C., Albert N.L. Serial 18F-FET PET imaging of primarily 18F-FET-negative glioma – does it make sense? J. Nucl. Med. 2016; 57: 1177–1182. DOI: 10.2967/jnumed.115.171033.

56. Weckesser M., Matheja P., Rickert C., Löttgen J., Palkovic S., Riemann B., Paulus W., Wassmann H., Schober O. Evaluation of the extension of cerebral gliomas by scintigraphy. Strahlenther. Onkol. 2000; 176 (4): 180–185.

57. del Amo E.M., Urtti A., Yliperttula M. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. Eur. J. Pharmaceut. Sci. 2008; 35 (3): 161–174. DOI: 10.1016/j.ejps.2008.06.015.